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Abstract 
ME/CFS is a serious illness affecting several hundred thousand British people. Some 25% of people with 
ME/CFS may be severely ill (housebound or bedbound), sometimes for decades. This observational, 
questionnaire-based study was designed to identify risk factors for severe disease. Exposure to potential risk 
factors, including familial risks, personality, and early management of the illness, was compared in 124 people 
with severe disease and 619 mildly ill controls. Severity was determined by self-report and the Barthel (activities 
of daily living) Index. Premorbid personality was assessed using the Neuroticism and Conscientiousness 
domains of the IPIP scale. Analysis was by tests of association and logistic regression. Early management of the 
illness appeared the most important determinant of severity. Having a mother with ME/CFS was also important. 
Smoking and personality were not risk factors, neurotic traits being more frequent among the less severely ill. 
Conscientiousness overall was not related to severity. 
 
Keywords: Chronic fatigue syndrome, myalgic encephalomyelitis, epidemiology, prognosis, severity, risk factors, 
treatment, management. 
 
 
Introduction 
ME/CFS is a serious problem affecting several 
hundred thousand people in Britain (CMO’s 
Working Group Report, 2002). Some 25% or 
more of people with ME/CFS may be severely 
ill (Action for ME, 2001), and may experience 
disabling and distressing symptoms confining 
them to their beds or their homes, sometimes 
for decades. They face social isolation, 
discrimination in employment and education 
and stigmatising, unhelpful attitudes from 
health, social care and other professionals. 
This study was designed to investigate risk 
factors for severe disease. An observational 
study, using a postal questionnaire, was 
undertaken to investigate risk factors for 
severe disease. Those investigated included 
personality factors, management at the outset 
of the illness, and a range of environmental 
and other factors. A pilot study (Wernham et 
al., 2005) was carried out initially, the results of 
which suggested that severe disease was 
associated with comorbidities, with 
inappropriate treatment in the early stages of 
the illness, and with occupational chemical 
exposures. This paper reports the findings of 
the definitive study.  
It is widely asserted (though not proven) that 
there is an association between personality 
and the initial development of ME/CFS. White 
et al (2000) suggest that individuals who have 
a dominant perfectionist character trait are at 
risk. Hamacheck (1978) describes two sorts of 
perfectionism – neurotic and normal. The 
normal perfectionist is able to derive 
satisfaction from achievement, and set 
themselves realistic goals, the ‘goalposts’ of 
which can be adjusted to suit the situation. 
Neurotic perfectionists, on the other hand, 
often set themselves targets that are 
unattainable, and, upon failing to meet a 
desired standard, feel unworthy and lack self-
esteem. Neurotic perfectionists are motivated 
by fear of failure and are dissatisfied the 
majority of the time. White et al (2000) argue 
that the low self esteem experienced by 
personalities more akin to the neurotic 
perfectionist could exert a pathological 
influence a person’s immune system at a time 
when a CFS-causing trigger is present, thus 
increasing the likelihood of succumbing to 
ME/CFS. People with ME/CFS are often told 
that their illness is a psychological disorder for 
which counselling is offered to change 
attitudes and promote a positive outlook (Bass, 
2001). While there is good reason to suggest 
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that a positive attitude will help in the 
prognosis of any disease including ME/CFS, 
there is little empirical evidence to support the 
assertion that attitudes, behaviour or 
underlying personality have a major role in 
determining outcomes.  
There have been few studies of the impact of 
early treatment on disease progression, but 
use of sedatives and antidepressants 
(Schmaling et al, 2000) and post-exertional 
malaise (Taylor et al., 2002) have been 
identified as risk factors. Most patients’ initial 
contact with the health care system is with 
primary care, but there has been little research 
on the outcomes of primary care interventions 
in ME/CFS. A small-scale randomised 
controlled trial of cognitive behavioural therapy 
in general practice showed no impact on the 
disease progression over a year (Whitehead 
and Campion P, 2002). There are barriers to 
effective care of patients with ME/CFS in the 
early stages of the disease, possibly related to 
negative attitudes held by health care 
professionals (Raine et al., 2004). Equally, 
delays and inappropriate treatment may be 
associated with socioeconomic factors 
impeding health care access (CMO’s Working 
Group Report, 2002).  
Severity is a major factor affecting prognosis, 
and there is more extensive literature on risk 
factors for poor prognosis. Severely ill patients 
tend to have poor prognoses, whether children 
(Ray et al., 1992) or adults (Pheley et al., 
1999; Hill et al., 1999), associated factors 
including having additional unexplained 
symptoms, prolonged disease, lower 
educational attainment, and more advanced 
age (Clark et al., 1995). This is confirmed by a 
systematic review conducted by Joyce et al 
(Joyce et al., 1997). Little is known about the 
reasons for the variations in prognosis found in 
ME/CFS, though recent research has identified 
several factors associated with such variation. 
Social, psychological, and physical factors 
have all been associated with severe illness 
and poor prognosis (Schmaling et al, 2000; 
Hartz et al., 1999).  
Factors associated with severe ME/CFS and 
poor prognosis in children include specific viral 
triggers, start date, and socioeconomic status 
(Rangel et al., 2000). In adults, co morbidities 
(White et al., 2000), exercise before falling ill 
(MacDonald et al., 1996; Van Houdenhove et 
al., 1995), and familial factors (Farmer et al., 
1999; Bell et al., 1991) have been implicated. 
The systematic review by Joyce et al (1997) 
concluded that consistently reported risk 
factors for poor prognosis include older age 
and illness that is more chronic. Other factors 
that have been claimed (Clark et al.,1995) to 
be associated with poorer prognosis include 
having more than eight medically unexplained 
physical symptoms separate from those 
associated with the ME/CFS case definition, 
having had chronic fatigue symptoms for more 
than 1·5 years, having less than 16 years of 
formal education; and being older than 38 
years. Cell-mediated immune function does 
not appear to affect prognosis (Wilson et al., 
1995; Peakman et al., 1997). There is some 
evidence that cases of acute onset have a 
better prognosis than those with gradual onset, 
and that epidemic cases have a better 
prognosis than sporadic cases (Levine, 1997).  
Methods 
An observational, questionnaire-based study 
was undertaken in which exposure to risk 
factors in people with severe disease was 
compared to that in controls with less severe 
disease. The South West Multi-Centre 
Research Ethics Committee granted ethical 
approval for the study. 
The participants in the study were recruited 
from members of voluntary organizations and 
patients attending NHS facilities. The ME 
Association, CHROME (Case History 
Research on ME), the 25% Group, the 
National ME Centre and the Wiltshire ME/CFS 
Service distributed 4000 questionnaires. 
Names and addresses of participants were 
unknown to the researchers. Reminders were 
sent by all organizations except the ME 
Association. Overall, 1166 questionnaires 
were returned, a response rate of 29%. 
Responses, 1104 in number, were included in 
the analysis if they confirmed medical 
diagnosis of ME/CFS and age over sixteen, 
and were assigned to mild, intermediate or 
severe groups on the basis of reported mobility 
status (i.e. whether housebound or bedbound 
or not) and Barthel score (Mahoney et al., 
1965) as an objective measure of physical 
disability, as set out in table 1. Accuracy of 
ascription was assessed by comparing pain 
levels, mood and cognitive dysfunction 
between groups.  
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Table 1: Definition of Severity Groups. 
Group No. of cases Criteria 
Mild 619 Not housebound or bedbound, and Barthel score 
70% + 
Intermediate 294 Barthel score 60% +, but <70%, or 
Not housebound or bedbound, but Barthel <70%, or 
Housebound or bedbound, but Barthel score 60% + 
Severe 124 Housebound or bedbound, and Barthel score <60% 
Unclassifiable 67 No response re whether housebound or bedbound, 
&/or 2 or more omissions in Barthel response 
TOTAL 1104  
 
Subsequent analyses focused on the 
comparison of the mild and severe groups, 
comprising 619 and 124 respondents 
respectively. The questionnaire sought 
information on exposure to possible risk 
factors, including familial risks, personality, 
pre-illness exposures including smoking, 
chemical exposures, occupation, exercise, 
immunisations, allergies, and infections in the 
month prior to the illness. Premorbid 
personality was assessed in the questionnaire 
using the Neuroticism and Conscientiousness 
domains of the International Personality Item 
Pool scale (Goldberg, 1999; Goldberg, 2001; 
IPIP, 2005). Between-group comparisons and 
tests were association were carried out. For 
chi squared tests involving 2x2 contingency 
tables, Yates’ correction was applied. Logistic 
regression analysis was undertaken to 
determine the relative importance of various 
risk factors in determining outcomes. 
Information was also sought on the 
consequences of illness, in particular ability to 
work. 
 
Results 
The results of the study are presented as 
follows. Following an overall description of the 
participants, and in particular of those with mild 
or severe disease, the accuracy of assignment 
of cases to mild or severe categories is 
assessed by consideration of the prevalence 
and severity of symptoms of pain and 
discomfort, cognitive problems and mood in 
these two groups. Then, the impact of possible 
risk factors in considered on a life-course 
basis, beginning with familial factors, 
progressing to personality, thence to pre-
illness exposures (smoking, chemicals, 
exercise, occupation, and biomedical factors, 
specifically immunisations, allergies, and 
infections. Differences between mild and 
severe cases as regards the consequences of 
having ME/CFS, e.g. in terms of occupation, 
are then explored, and finally a logistic 
regression analysis, to identify which factors 
appeared most important in determining 
severity, is reported.  
 
Description of the respondents 
Females constituted a significantly higher 
proportion of the severe group than of the mild 
group. The average age of respondents with 
mild disease was 49.1 years, and for 
respondents with severe disease it was 43.7. 
The average age of onset of ME/CFS was 
38.1 for mild cases and 30.6 for severe cases. 
Severe cases were more likely than mild cases 
to have juvenile onset disease, 25.0% 
reporting that their illnesses started at age 
below twenty, compared with 8.4% of mild 
cases (chi sq. = 47.45, p <0.001). The 
proportion of females rose with severity. They 
constituted 72.1% of mild, 81.0% of 
intermediate, and 88.7% of severe cases. The 
unclassifiable group included 68.6% females. 
(chi sq. = 21.45, with 2 degrees of freedom, 
i.e. disregarding the unclassifiable cases; p < 
0.0000219). 
 
Accuracy of assignment 
Patterns of symptomatology reported by mild 
and severe respondents were compared, in 
order to confirm the accuracy of assignment of 
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respondents to these two groups. The findings 
reported are in respect of pain, cognitive 
dysfunction and mood. 
 
Pain or discomfort   
Participants in the severe category reported 
much more pain than mild cases, both 
immediately and over the previous four weeks. 
This difference was highly significant. 
However, few participants in either category 
were entirely free of pain (table 2). 
 
Table 2: Pain Levels and Cognitive Problems. 
Pain: 
  None at all Mild or 
moderate 
Severe/very 
severe 
TOTAL Chi sq. p 
During the past four weeks 
Mild 
cases No. cases 57 415 149 621 
101.20 <0.000001 
 % total 9.2 66.8 24.0 100.0   
Severe 
cases No. cases 2 34 85 121 
  
 % total 1.7 28.1 70.2 100.0   
Now 
Mild 
cases No. cases 90 450 77 617 
98.55 <0.000001 
 % total 14.6 72.9 12.5 100.0   
Severe 
cases No. cases 1 60 60 121 
  
 % total 0.8 49.6 49.6 100.0   
Cognitive Problems: 
  Never Sometimes/ 
infrequently 
Frequently/ 
often 
   
Are your thoughts muddled or slow? 
Mild 
cases No. cases 25 332 262 619 25.39 0.000003 
 % total 4.0 53.6 42.3 100.0   
Severe 
cases No. cases 3 37 82 122   
 % total 2.5 30.3 67.2 100.0   
Do you get confused about what time of day it is, where you are or who people are? 
Mild 
cases No. cases 278 268 70 616 27.99 <0.000001 
 % total 43.5 43.5 11.4 100.0   
Severe 
cases No. cases 52 52 35 122   
 % total 42.6 42.6 28.7 100.0   
Do you lose track of what is being said in the middle of a conversation? 
Mild 
cases No. cases 73 322 226 621 121.17 <0.000001 
 % total 11.8 51.9 36.4 100.0   
Severe 
cases No. cases 3 39 80 122   
 % total 2.5 32.0 65.6 100.0   
Do you forget the names of people in your family or friends whom you see regularly? 
Mild 
cases No. cases 229 275 114 618 8.48 0.014 
 % total 37.1 44.5 18.4 100.0   
Severe 
cases No. cases 35 50 36 121   
 % total 28.9 41.3 29.8 100.0   
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Cognition and mood  
 In respect of every question bearing on 
cognition that respondents were asked, the 
proportion of severe cases reporting problems 
frequently or often was much greater than 
among mild cases. In every case, this 
difference was highly significant, except in 
response to the question ‘Do you forget the 
names of people in your family or friends 
whom you see regularly?’ (table 2) 
 
In toto, eleven hypotheses re mood and 
cognitive function were examined, so a 
Bonferroni correction has been made, with a 
revised alpha of 0.0045. There was no 
difference in current anxiety levels between 
severe and mild cases. However, severe 
cases were significantly more likely to be 
depressed than mild cases. On this basis, the 
only significant difference between severe and 
mild cases was that a higher proportion of 
severe cases reported that they had not been 
happy any time in the previous four weeks. 
However, this proportion (10.7%) was still very 
low (table 3).  
 
 
Table 3: Mood Variations by Severity. 
 
  Not at all Mildly or 
moderately 
Severely/ 
very severely 
TOTAL Chi sq. P 
Whether anxious now 
Mild 
cases No. cases 244 326 49 619 3.678 0.159 
 % total 39.4 52.7 7.9 100.0   
Severe 
cases No. cases 43 62 16 121 
  
 % total 35.5 51.2 13.2 100.0   
Whether depressed now 
Mild 
cases No. cases 337 258 24 619 22.868 0.000011 
 % total 54.4 41.7 3.9 100.0   
Severe 
cases No. cases 58 45 17 120 
  
 % total 48.3 37.5 14.2 100.0   
Mood over the past four weeks: Have you:- 
  None of the 
time 
Some/a little 
of the time 
All/much of the 
time 
   
 been very nervous? 
Mild 
cases No. cases 202 340 83 625 6.72 0.035  
 % total 32.3 54.4 13.3 100.0   
Severe 
cases No. cases 37 57 27 121   
 % total 30.6 47.1 22.3 100.0   
  felt so down in the dumps that nothing could cheer you up? 
Mild 
cases No. cases 179 291 75 545 6.311 0.043 
 % total 32.8 53.4 13.8 100.0   
Severe 
cases No. cases 44 52 26 122   
 % total 36.1 42.6 21.3 100.0   
  felt calm and peaceful? 
Mild 
cases No. cases 63 329 230 622 1.885 0.39 
 % total 10.1 52.9 37.0 100.0   
Severe 
cases No. cases 18 63 45 126   
 % total 14.3 50.0 35.7 100.0   
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  felt downhearted and low? 
Mild 
cases No. cases 69 431 121 621 6.182 0.045 
 % total 11.1 69.4 19.5 100.0   
Severe 
cases No. cases 6 83 32 121   
 % total 5.0 68.6 26.4 100.0   
  been happy? 
Mild 
cases No. cases 23 331 268 622 10.953 0.004 
 % total 3.7 53.2 43.1 100.0   
Severe 
cases No. cases 13 63 46 122   
 % total 10.7 51.6 37.7 100.0   
 
Exposure to Potential Risk Factors 
Familial factors   
37.9% of severe cases reported a family 
history of ME/CFS, compared with only 17.1% 
of mild cases. This was statistically highly 
significant (chi sq. for mild in comparison with 
severe cases = 6.45; p = 0.011). There was a 
strong association between having a mother 
with ME/CFS and developing severe disease, 
less strong associations with having a sibling 
or child with ME/CFS, and no association at all 
with having a father with the illness (table 4). 
 
Table 4: Relatives who have had ME/CFS. 
Relative Cases Chi sq. p 
 Mild (n = 630) Severe (n = 120)   
ME/CFS No 
ME/CFS 
ME/CFS No 
ME/CFS 
  
         
Mother No. cases 22 581 14 106 11.96 0.00023 
 % total 3.5 96.5 11.7 88.3   
        
Father No. cases 7 596 3 117 0.517 0.472 
 % total 1.1 98.9 2.5 97.5   
        
Brother or 
sister 
No. cases 24 579 14 106 10.381 0.0013 
 % total 3.8 96.2 11.7 88.3   
        
Son or 
daughter 
No. cases 28 575 11 109 3.175 0.075 
 % total 4.4 95.6 9.2 90.8   
        
Any first degree 
relative 
No. cases 69 561 26 94 9.514 0.002 
 % total 10.9 89.1 21.7 78.3   
         
Any other 
relative 
No. cases 13 590 24 96 62.006 <0.00001 
 % total 2.1 97.9 20.0 80.0   
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Personality   
Two personality domains were investigated 
using IPIP (27, 28, 29), viz. neuroticism and 
severity. A logistic regression analysis 
indicated an inverse association between 
neuroticism and severity, but none between 
conscientiousness and severity (Table 5). The 
association remained significant when sex and 
age were excluded from the model.  
 
Table 5: Odds Ratios for Severity – Logistic Regression Results. 
 Odds Ratio  (95% Confidence Interval) 
 Four variable model Two variable model 
Variable:   
Age now  0.74    (0.66 - 0.87) - 
Sex  0.38    (0.21 - 0.70) - 
Conscientiousness  0.99    (0.58 - 1.72) 0.77  (0.46 - 1.29) 
Neuroticism         0.51    (0.35 - 0.75) 0.42  (0.26 - 0.69) 
Summary Statistics   
Chi Square 40.29 (df=4) 13.05 (df=2) 
P <0.05 <0.05 
 
Mean scores for neuroticism were consistently 
higher among mildly ill subjects than among 
the severely ill. This was true also of all sub 
domains of neuroticism (Figure 1, and Table 
6), average scores being consistently higher 
among mild cases for immoderation, self-
consciousness, vulnerability, depression, 
anger and anxiety. Logistic regression analysis 
showed that the sub-domains of anger, anxiety 
and vulnerability were more strongly 
associated with severity. 
 
Figure 1: Neuroticism Sub-domains: Mean Scores by Severity. 
 
0 0.5 1 1.5 2 2.5 3
Means
Neuroticism
summary score
Anxiety
Anger
Depression
Vulnerability
Self
consciousness
Immoderation
Severe Mild
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Table 6: Comparison of Mean Scores for Neuroticism in Severe and Mild Cases. 
 
 Mean Score Ratio of Mean 
Scores  Severe  cases Mild cases (Mild: Severe) 
Neuroticism summary score 
 
1.87 2.05 1.10 
Sub-Domain: 
 
   
Anxiety 2.04 2.42 1.19 
Anger 2.44 2.84 1.16 
Depression 1.99 2.30 1.16 
Vulnerability 2.05 2.35 1.15 
Self consciousness 2.38 2.65 1.11 
 
An independent samples t-test indicated no 
significant difference between the mild and 
severe groups for any of the 
conscientiousness sub-domains (Figure 2 and 
Table 7). However, logistic regression 
indicated that, while the sub-domains of 
orderliness, dutifulness, perfectionism and 
cautiousness were not risk factors for severity, 
self-efficacy and self-discipline were. a high 
self efficacy score was associated with an 
increase in the risk of being severely ill of 70%, 
while for self discipline a high score was 
associated with an increase in the level of risk 
of 64%.  
 
 
Figure 2: Conscientiousness Sub-domains and Severity. 
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Table 7: Conscientiousness and Severity: Logistic Regression Analysis. 
 Odds Ratio 95% Confidence 
Interval 
High self-efficacy score  1.70 1.12 – 2.57 
High self discipline  1.64 1.07 -  2.50 
High conscientiousness  0.98 0.65 – 1.48 
High orderliness  1.14 0.75 – 1.72 
High dutifulness  0.82 0.54 – 1.24 
High perfectionism  1.07 0.71 -  1.62 
High cautiousness  1.70 1.12 – 2.57 
 
Pre-Illness exposures 
There was no association between smoking 
habits and development of severe ME/CFS 
(table 8) (chi sq. (Current smokers v. Non-
smokers) = 2.45; p = 0.118). Severely ill 
subjects were more likely than mild cases to 
have reported exercising six or more hours per 
week prior to falling ill (chi sq. = 6.4; p = 0.009) 
(table 9). As regards last occupation before 
developing ME/CFS, homemakers and 
students were over-represented in the severe 
category, while teachers and academics were 
under-represented (table 10). Working night 
shifts before falling ill was not a risk factor for 
severity. 20.8% of severe respondents (16 out 
of 77) did so, and 15.6% (79 out of 597) mild 
ones (chi sq. = 0.97; p = 0.324). 
 
 
Table 8: Smoking, and Reported Exposure to Chemicals. 
 Mild  Severe  
 No. Cases % total No. Cases % total 
Smoking Behaviour: 
 Non-Smoker 397 65.0 70 58.3 
 Ex-Smoker 157 25.7 33 27.5 
 Current smoker 57 9.3 17 14.2 
 Total 611 100.0 120 100.0 
Reported Chemical Exposures: 
 Yes, at work 111 23.8 29 27.4 
 Yes, at home 30 6.4 25 23.6 
 No 326 69.8 52 49.1 
 Total 467 100.0 106 100.0 
 
 
 
 
 
Research Article      Biology and Medicine, Vol 1 (4): 50-74, 2009 
59 
 
Table 9: Exercise prior to falling ill. 
Hours/week Mild  Severe  
 No. cases % total No. cases % total 
<1 34 5.7 7 5.8 
1 to 2 79 13.1 8 6.6 
2 to 3 85 14.1 17 14.0 
3 to 4 79 13.1 10 8.3 
4 to 5 81 13.5 14 11.6 
6 or more 243 40.4 65 53.7 
TOTAL 601 100.0 121 100.0 
 
 
Table 10: Last occupation before developing ME/CFS. 
 Mild Severe Chi-sq.* p 
 No. cases % total 
No. 
Cases % total   
Teacher/academic 134 24.3 13 11.4 8.369 0.0038167 
Secretary/Office 
worker/administrator 131 23.7 26 22.8 0.008 0.9287300 
Student 47 8.5 27 23.7 20.506 0.0000027 
Healthcare professional 84 15.2 9 7.9 3.63 0.0567468 
Housewife 21 3.8 14 12.3 11.985 0.0005363 
Manual worker 24 4.3 6 5.3 0.033 0.8558503 
Retired 13 2.4 2 1.8 0.002 0.9643294 
Other 98 17.8 17 14.9 0.354 0.5518575 
TOTAL 552 100.0 114 100.0   
 
* Category v. all others  
 
There was a difference in reported exposure to 
chemicals at home, but not at work, between 
severe and mild cases which appears highly 
significant (Chi sq. (all exposures) = 15.66; p = 
0.00076. For home exposures, chi sq. = 27.38, 
p <0.000001; for occupational exposures, chi 
sq. = 0.424; p = 0.52). However, this must 
interpreted with caution, since self-reported 
exposures are notoriously unreliable, and likely 
to be influenced by post hoc rationalisation. 
Information was given about the nature of the 
claimed exposures in a small minority of cases 
(table 8). Where information about the nature 
of chemical exposures was given, it tended to 
be vague, and no pattern emerged as to which 
specific chemical or class of chemical was 
being blamed for the subsequent development 
of illness. Responses were analysed according 
to whether claimed exposures were specific 
(i.e. specific chemical identified), unspecific 
(class of substance but no specific chemical 
identified), or vague (neither class of 
substance nor specific chemical identified) 
(table 11). Mildly ill people were more likely to 
have reported a specific chemical exposure 
than severely ill people (i.e. 21 of 62 mild 
cases (33.9%), compared with 4 out of 27 
severe cases (14.8%), but this was not 
statistically significant (Chi sq.  = 2.504; p = 
0.114). Exposure to agricultural/horticultural 
chemicals was reported by 50% of those 
severe cases reporting exposures (24 out of 
48) and 33.9% (21 out of 62) mild cases. This 
difference was not statistically significant (chi 
sq. = 2.28; p = 0.131). 
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Table 11: Specificity of Chemical Exposure Reports. 
Category Mention of:-  
 Agriculture/ 
horticulture 
Construction 
industry 
Other TOTAL 
Occupational exposures:     
Mild cases:     
 Specific 2 1 9 12 
 Unspecific 2 2 10 14 
 Vague 1 1 6 8 
 TOTAL 5 4 25 34 
Severe cases:     
 Specific 0 0 2 2 
 Unspecific 1 0 3 4 
 Vague 1 1 2 4 
 TOTAL 2 1 7 10 
     
ALL OCCUPATIONAL EXPOSURES 7 5 32 44 
     
Home exposures:     
Mild cases:     
 Specific 6 2 1 9 
 Unspecific 5 2 1 8 
 Vague 5 1 5 11 
 TOTAL 16 5 7 28 
Severe cases:     
 Specific 1 0 1 2 
 Unspecific 9 3 3 6 
 Vague 0 0 0 0 
 TOTAL 10 3 4 17 
     
ALL HOME AND LIVING EXPOSURES 20 6 11 37 
     
OVERALL TOTAL (all categories) 27 11 43 81 
 
 
 
There were few variations in respect of pre-
illness biomedical factors between the severe 
and mild categories As regards immunisation 
rates, severe cases were significantly less 
likely to have been immunised against 
hepatitis B and smallpox (NB. 10 related 
hypotheses were tested, so a revised alpha 
value, following the Bonferroni procedure, of 
0.005 was adopted) (Table 12).  For every 
category of potential allergen enquired about 
except for pollen, a higher proportion of 
respondents in the severe category than in the 
mild category reported allergies. These 
variations were statistically significant only in 
the cases of drugs and cosmetics (NB. 7 
related hypotheses were tested, so a revised 
alpha value, following the Bonferroni 
procedure, of 0.007 was adopted). 86.7% 
severe cases, and 78.1% of mild cases, 
reported having had an infection in the month 
before they fell ill (chi sq. = 4.169; p = 0.041). 
This was weakly significant, as was the more 
frequent reporting of Epstein-Barr virus 
infection among severe cases (table 12). 
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Table 12: Immunisations, Allergies, and Infections in the month prior to illness. 
 Mild cases Severe cases Chi 
sq. 
p 
 No. 
cases 
% 
total 
Total 
(= 100%) 
No. 
cases 
% 
total 
Total 
(= 100%) 
  
Immunisations 
  Cholera 113 20.3 556 21 18.7 115 0.14 0.707 
  Diphtheria 319 55.5 575 59 50.4 117 0.81 0.369 
  Measles 254 44.6 570 59 50.0 118 0.96 0.328 
  Mumps 205 36.5 562 38 32.2 118 0.60 0.438 
  Typhoid 177 31.9 554 25 21.9 114 4.04 0.045 
  Hepatitis B 163 29.1 561 16 13.9 115 10.48 0.001 
  Poliomyelitis 512 85.0 602 94 78.3 120 2.87 0.090 
  Rubella 278 48.4 574 65 55.6 117 1.70 0.193 
  Smallpox 283 49.4 573 37 31.4 118 12.08 0.0005 
  Tetanus 534 88.7 602 97 80.2 121 5.87 0.015 
Allergies: 
  Food  232 44.8 518 68 57.6 118 5.85 0.016 
  Pollen 192 36.9 520 44 37.0 119 0.009 0.992 
  Drugs 184 36.0 511 64 53.8 119 12.04 0.00035 
  Cosmetics 184 36.6 516 64 54.2 118 12.59 0.00039 
  Animals 139 27.4 508 32 27.4 117 0.013 0.909 
  House dust mite 98 19.5 502 35 29.9 117 5.48 0.019 
  Other 116 23.2 499 34 29.3 116 1.56 0.211 
  ALL ALLERGENS 451 72.4 623 110 88.7 124 13.87 0.0002 
Infections in month before illness 
  Coxsackie 41 8.2 499 10 9.2 109 0.019 0.890 
  EBV 66 13.1 504 23 21.5 107 4.352 0.037 
  Other viruses 306 26.1 532 55 49.1 112 2.327 0.127 
  Other (non-viral)  59 11.8 499 18 16.2 111 1.215 0.270 
 
 
 
 
Management in the early stages of the illness 
There was a significant difference between the 
mild and groups in the interval between falling 
ill and diagnosis. 336 out of 611 respondents 
with mild disease (55.0%) were diagnosed in 
less than a year. For severe cases, the 
proportion was 41.7% (50 out of 120 cases) 
(chi sq. = 6.62; p 0.01).  As well as being more 
likely than mild cases to experience diagnostic 
delays, severe cases were more likely to 
encounter social problems in the early stages 
of the illness. This applied in every area 
investigated, in the  family,  education,  in  the  
home,  and  in  the  social  security  system. 
The workplace was the only exception, where 
mild cases were significantly more likely than 
severe cases to have encountered problems 
(Table 13). 
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Table 13: Social problems encountered in the early stages of the disease. 
 
 Mild Severe Chi 
sq. 
p 
 Yes No Yes No   
 No. 
case
s 
Col. 
% 
No. 
case
s 
Col. 
% 
No. 
cases 
Col. 
% 
No. 
case
s 
Col. 
% 
  
Work 402 71.5 160 28.5 63 52.9 56 47.1 14.82 0.0001 
Social security 
benefits 175 33.0 356 67.0 53 44.9 65 55.1 5.55 0.019 
Family 187 34.7 352 65.3 64 54.2 54 45.8 14.85 0.0001 
Education 58 11.2 462 88.8 33 27.7 86 72.3 20.45 0.000006 
Lack of support 
in the home 152 28.4 383 71.6 55 45.8 65 54.2 12.97 0.0003 
Other 97 18.8 420 81.2 45 37.8 74 62.2 19.17 0.00001 
 
 
 
Two-thirds of the respondents received 
treatment in the early stages of the illness 
(66.6% of mild cases, and 67.7% of severe 
cases). Among those subjects who did receive 
treatment in the early stages of the illness, 
32.7% of mild cases (98 out of 300) found 
treatment in the early stages of the illness to 
be useful, compared with only 11.5% of severe 
cases (6 out of 52) (chi sq. = 8.52; p = 0.0035). 
By contrast, 73.1% of severe cases found it 
damaging, compared with only 30.0% of mild 
cases (chi sq. = 44.7; p <0.00001). Among 
those subjects who received treatment before 
diagnosis, people with severe disease were 
significantly more likely to have received 
analgesics, physiotherapy, or complementary 
therapy than people with mild disease. There 
were no significant differences in any other 
type of treatment. After diagnosis, the 
proportions of both mild and severe cases 
receiving treatment rose markedly, and severe 
cases were very significantly more likely than 
mild cases to have received physiotherapy 
(Table 14). 
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Table 14: Patterns of Treatment in the Early Stages of the Illness. 
 
 Before Diagnosis Immediately after Diagnosis 
 Mild Severe Chi2  P Mild Severe Chi2  P 
 No. cases 
% total 
(n = 623) 
No. 
cases 
% total 
(n = 124)   
No. 
cases 
% total 
(n = 623) 
No. 
cases 
% total 
(n = 124)   
Pain killers 193 31.0 46 37.1 8.733 0.003 199 31.9 51 41.1 3.518 0.061 
Tranquillisers 56 9.0 15 12.1 0.828 0.363 42 6.7 12 9.7 0.927 0.336 
Antidepressants 190 30.5 36 29.0 0.047 0.828 257 41.3 69 55.6 8.135 0.004 
Other drugs 97 15.6 20 16.1 0.000 1.000 88 14.1 24 19.4 1.828 0.176 
Physiotherapy 35 5.6 20 16.1 15.246 0.00009 68 10.9 29 23.4 13.155 0.0003 
Occupational therapy 7 1.1 4 3.2  0.070# 47 7.5 17 13.7 4.262 0.039 
Activity management 19 3.0 4 3.2  0.217# 115 18.5 26 21.0 0.277 0.599 
Complete bed rest 77 12.4 15 12.1 0.005 0.944 64 10.3 19 15.3 2.183 0.140 
Graded exercise 23 3.7 11 8.9 5.249 0.022 100 16.1 22 17.7 0.110 0.740 
Cognitive behaviour 
therapy 18 2.9 8 6.5 2.918 0.088 53 8.5 9 7.3 0.080 0.777 
Counselling 49 7.9 16 12.9 2.700 0.100 99 15.9 25 20.2 1.071 0.301 
Complementary 
therapies 75 12.0 28 22.6 8.802 0.003 152 24.4 25 20.2 0.806 0.369 
Other treatment 62 10.0 21 16.9 4.424 0.035 89 14.3 19 15.3 0.026 0.872 
ALL TREATMENTS 415 66.6 84 67.7 0.019 0.890 506 81.2 111 89.5 4.518 0.036 
# Fisher’s Exact Test 
NB. Probability values in BOLD are significant at a revised α-threshold of 0.0036, following the Bonferroni procedure 
 
For ALL TREATMENTS, the increase after diagnosis in the proportion of patients receiving treatment was statistically significant, i.e.:- 
Mild cases:  Chi sq. = 33.092; p <0.00001 
Severe cases: Chi sq. = 16.221; p <0.00001 
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There were few respondents for whom there 
was no professional involvement in their initial 
treatment, and there was no significant 
difference between mild and severe cases in 
the proportions with professional involvement 
in their initial treatment. Most respondents, of 
both categories, reported that at least one 
helpful professional was involved in their initial 
care after diagnosis, though severe cases 
reported this less frequently than mild cases, 
i.e. 501 out of 623 mild cases (80.4%), 
compared with 76 out of 124 severe cases 
(61.3%). This difference was statistically 
significant (chi sq. = 20.50, p = 0.000006). 
 
The GP was the professional most commonly 
consulted by people with ME/CFS in the early 
stages of their illnesses, being consulted by 
79.9% of people with mild disease and 77.6% 
of people with severe disease. The proportion 
of respondents reporting a bad relationship 
with their GP was significantly higher among 
severe cases than mild ones, both before and 
after diagnosis, even though overall most 
respondents reported good relationships with 
their GPs (table 5). In both categories, the 
proportion of respondents reporting bad 
relationships with their GPs rose significantly 
after diagnosis (mild cases: chi sq. by 
McNemar’s test = 19.04, p = 0.0001; severe 
cases: chi sq. = 4.15, p = 0.042). 
 
Severe cases were more likely to have been 
diagnosed by hospital doctors, and less likely 
to have been diagnosed by GPs, than mild 
cases. However, this difference was not 
statistically significant (table 15). Psychiatrists, 
other hospital doctors, nurses, and social 
workers were significantly more likely to have 
been involved in the initial treatment of severe 
cases than of mild cases. (Table 16). 
 
 
 
 
 
 
 
Table 15: Respondents’ Relationships with Doctors. 
 
 Mild Severe Chi sq. P 
 No. % No. %   
Doctor making initial diagnosis 
GP 488 81.6 91 76.5 1.369 0.242 
Hospital doctor 93 15.6 24 20.2 1.229 0.268 
Other 17 2.8 4 3.4  0.210# 
TOTAL 598 100.0 119 100.0   
Relationship with GP before diagnosis 
Good 401 65.8 62 50.4 9.840 0.002 
Bad 29 4.8 19 15.4 17.364 0.00003 
Neither good nor bad 179 29.4 42 34.1 0.883 0.347 
TOTAL 609 100.0 123 100.0   
Relationship with GP immediately after diagnosis 
Good 398 65.1 51 42.5 20.750 0.000005 
Bad 72 11.8 33 27.5 18.883 0.00001 
Neither good nor bad 141 23.1 36 30.0 2.256 0.133 
TOTAL 611 100.0 120 100.0   
# Fisher’s Exact Test 
NB. Probability values in BOLD are significant at α-threshold of 0.05. 
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Table 16: Professionals involved in Initial Treatment. 
 
 Mild Severe Chi sq. P 
 No. % No. %   
Professional involved 553 88.8 106 85.5 0.778 0.378 
No professional involved 70 11.2 18 14.5   
TOTAL 623 100.0 124 100.0   
 
GP 498 79.9 95 76.6 0.509 0.476 
Psychiatrist 79 12.7 35 28.2 18.141 0.00002 
Other hospital doctor 237 38.0 65 52.4 8.289 0.004 
Nurse 32 5.1 16 12.9 9.124 0.003 
Occupational therapist 43 6.9 18 14.5 7.012 0.008 
Physiotherapist 64 10.3 23 18.5 6.102 0.014 
Clinical psychologist 43 6.9 11 8.9 0.340 0.560 
Counsellor 61 9.8 20 16.1 3.666 0.566 
Social worker 13 2.1 17 13.7 33.291 <0.00001 
Complementary therapist 108 17.3 21 16.9 0.001 0.975 
Other 61 9.8 14 11.3 0.118 0.731 
 
NB. Probability values in BOLD are significant at a revised α-threshold of 0.0045, following the 
Bonferroni procedure 
 
 
 
Table 17 summarises the extent to which 
respondents found the attitudes of 
professionals involved in their initial care after 
diagnosis helpful or unhelpful. It will be noted 
that severe cases were significantly less likely 
than mild cases to have found helpful the 
involvement or clinical psychologists, and 
significantly more likely to have unhelpful the 
involvement of social workers. As regards 
GPs, a significantly higher proportion of mild 
cases than of severe cases found their 
involvement helpful, while a significantly lower 
proportion of mild cases than of severe cases 
found their involvement unhelpful. There were 
no significant differences in respect of other 
professionals, but in many instances, the 
numbers of cases were very small. Mildly ill 
subjects reported that the professionals they 
consulted were helpful far more frequently 
than they reported that they were unhelpful. 
This was also true, though less markedly so, 
for severely ill subjects, except as regards 
clinical psychologists, who were much more 
frequently reported by severely ill patients to 
be unhelpful than to be helpful, though this 
was not statistically significant (chi sq. = 0.406, 
p = 0.52). 
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Table 17: Attitudes of professionals involved in initial care after diagnosis. 
 
 Mild cases Severe cases 
Chi 
sq. P 
 No. % Total No. % Total   
Respondents finding professional involvement helpful 
 GP 377 74.8 504 47 58.0 81 9.024 0.0027 
Psychiatrist 58 60.4 96 16 61.5 26 0.015 0.905 
Other hospital doctor 159 61.2 260 38 58.5 65 0.065 0.799 
Nurse 29 64.4 45 11 50.0 22 0.751 0.386 
Occupational therapist 44 75.9 58 14 73.7 19 0.013 0.909 
Physiotherapist 48 67.6 71 13 50.0 26 1.829 0.176 
Clinical psychologist 42 67.7 62 4 26.7 15 6.851 0.0088 
Counsellor 50 78.1 64 15 75.0 20 0.000 1.000 
Social worker 14 77.8 18 9 64.3 14 4.655 0.031 
Complementary therapist 108 85.0 127 19 76.0 25 0.671 0.413 
Other professional 52 77.6 67 11 68.8 16 0.176 0.675 
Participants finding professional involvement unhelpful 
GP 73 14.5 504 23 28.4 81 8.857 0.0029 
Psychiatrist 33 34.4 96 9 34.6 26 0.044 0.834 
Other hospital doctor 67 25.8 260 22 33.8 65 1.324 0.250 
Nurse 10 22.2 45 9 40.9 22 1.703 0.192 
Occupational therapist 9 15.5 58 4 21.1 19  0.224# 
Physiotherapist 18 25.4 71 10 38.5 26 1.018 0.313 
Clinical psychologist 13 21.0 62 8 53.3 15 4.851 0.028 
Counsellor 8 12.5 64 4 20.0 20  0.190# 
Social worker 3 16.7 18 5 35.7 14  0.0091# 
Complementary therapist 13 10.2 127 5 20.0 25  0.098# 
Other professional 11 16.4 67 4 25.0 16  0.235# 
 
# Fisher’s Exact Test 
 
 
 
 
Logistic regression 
A logistic regression model was constructed in 
order to review the relative contributions of the 
range of factors, which appeared to be 
increasing the risk of severe disease. The 
initial model comprised 24 independent 
variables. 587 mild and 116 severe cases 
were included in the model. This was highly 
significant (Initial chi sq. (-2 Log Likelihood) = 
629.72; p <0.00001). The variables are listed, 
together with univariate chi squared results 
and probabilities, in Table 18.  
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Table 18: The Initial Overall Logistic Regression Model. 
Description Chi sq. 
(variable v. 
severity) 
p 
   
Conscientiousness summary score  2.422 0.298 
Neuroticism summary score  12.596 0.0056 
Gender  9.934 0.0016 
Family history of ME/CFS  8.858 0.0029 
History of ME/CFS in mother  5.345 0.0208 
Hours of exercise per week before illness  10.642 0.1001 
Hepatitis B immunisation  8.266 0.0040 
Smallpox vaccination  7.212 0.0072 
Occupation  38.109 <0.0001 
Infection in month prior to illness   3.635 0.0566 
EBV Infection in month prior to illness   2.816 0.0933 
Problems at work at outset of illness  6.391 0.0115 
Problems with social security at outset 24.032 <0.0001 
Family difficulties at outset 4.438 0.0351 
All allergens  14.455 0.0001 
Interval between falling ill and diagnosis  12.991 0.0015 
Value of initial treatment  19.940 <0.0001 
Antidepressants after diagnosis  5.886 0.0115 
Relationship with GP before and after 
diagnosis  
28.519 <0.0001 
Psychiatrist involved in initial treatment  11.224 0.0008 
At least one helpful health professional  3.326 0.0681 
 
The model was refined by successive deletion 
of variables. Firstly, where variables appeared 
covariate, those with the weaker associations 
with the dependent variable were deleted. 
Then variables were deleted in sequence, in 
order of weakness of association with the 
outcome variable. Eventually a six variable 
model was obtained, in which chi sq. = 633.37 
(p<0.00001). Thus, successive deletions had 
no impact on the predictive power of the 
model. The independent variables in the final 
model were: 
 Occupation 
 Problems with social security 
 Interval between falling ill and diagnosis 
 Perceived value of initial treatment 
 Relationship with GP before and after 
diagnosis 
 Involvement of a psychiatrist in initial 
treatment 
 
Consequences of severity 
2.5% of those with severe ME claimed to be 
still working at the job they had had 
immediately before falling ill, compared with 
21.2% of mild cases (chi sq. (still working v not 
working or retired) = 22.50; p = 0.000001). It is 
clear from comments made by respondents, 
though, that many of those still working were 
clinging on with some considerable difficulty, 
e.g. these comments from mildly affected 
respondents:- “Only just”, “Up to a point”, “Part 
time - long break”, “But off sick again with ME”. 
 
4 out of 6 severe cases (66.7%) who claimed 
to be still working were working less than 10 
hours per week, compared with 32 out of 174 
(18.4%) mild cases (p by Fisher’s Exact Test = 
0.0014). Only 13.8% of respondents were still 
able to do the job they had immediately before 
falling ill (i.e. 29 out of 136). Of the 82.6% who 
were unable, to do so, 288 (30.8%) had retired 
on medical grounds. As might be expected, 
manual workers were least able to continue 
their previous jobs, i.e. only 2 out of 44, or 
4.3%, compared with 128 out of 775 others 
(14.2%) (p by Fisher’s Exact Test = 0.028) 
 
Discussion 
The accuracy of assignment to mild and 
severe categories appears to have been high, 
given the differences between the two groups 
in reported symptom frequency and severity, 
and also in terms of the consequences of 
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illness experienced by the two groups, as 
practically no severe cases were still working 
at their pre-illness job, and only a small 
minority of mild cases. As might be expected, 
manual workers were least able to continue 
their previous jobs. As regards last occupation 
before developing ME/CFS, homemakers and 
students were over-represented in the severe 
category, while teachers and academics were 
under-represented. Working night shifts before 
falling ill was not a risk factor. 
 
Major risk factors for severe disease included 
being female, and having a family history of 
ME/CFS. Early management of ME/CFS 
appeared also to be a major determinant of 
severity. The logistic regression model was 
refined without loss of precision to a final 
model comprising just six variables, viz. 
occupation, problems with social security, 
interval between falling ill and diagnosis, 
perceived value of initial treatment, 
relationship with GP before and after 
diagnosis, and involvement of a psychiatrist in 
initial treatment, all but one of which, it will be 
noted, pertain to the management of the 
condition in its early stages.  
 
Personality type did not appear to constitute a 
risk factor for severe disease. This was also 
the conclusion of another recent study, a 
controlled study of 36 patients, which 
determined that  personality structure does not 
appear to play a major role in CFS (Le Bon et 
al., 2007) Our investigation of the possible role 
of personality revealed an inverse association 
between neuroticism and severity, but none 
overall between conscientiousness and 
severity. Mean scores for neuroticism were 
consistently higher among mildly ill subjects 
than among the severely ill. This may indicate 
either that severely ill people may develop a 
degree of stoicism that affects their responses 
to personality questionnaires. Indeed, a 
recently published case study indicates that 
personality profile can indeed be affected by 
having CFS (Van Hoof et al., 2007). 
Alternatively, it may indicate, as we were 
unable to validate diagnoses, that the mild 
group included people who did not actually 
have ME/CFS at all, but other fatiguing 
illnesses in which personality may play a part. 
In the conscientiousness domain, though there 
was no association overall with severity, the 
sub-domains of self-efficacy and self-discipline 
were associated with it. This may be in part a 
consequence of the low response rate. 
Completion of the questionnaire was 
undoubtedly a major challenge for many who 
were severely ill, so only the most motivated 
and driven of severely ill people, i.e. those with 
high self-efficacy and self-discipline scores, 
may have persevered with it to the end.  
 
Other less marked associations with severity 
included an increased likelihood among severe 
cases of having been immunised against 
hepatitis B and smallpox, of having reported 
allergies (except to pollen), or an infection in 
the month before they fell ill, and of having 
exercised six or more hours per week before 
falling ill. There were some differences in 
alleged chemical exposures between the mild 
and severe groups. However, these must be 
interpreted with caution, since self-reports of 
exposures are inherently unreliable and likely 
to be influenced by post hoc rationalisation. 
Information given was in any case vague and 
fragmentary. More research is clearly needed 
in this area before definitive conclusions can 
be drawn. There was no association between 
smoking habits and development of severe 
ME/CFS.  
 
The finding that having a family history was a 
risk factor for ME/CFS is consistent with that of 
a twin study (Farmer et al., 1999) and a study 
of an epidemic outbreak in New York State 
(Bell et al., 1991). A recent study found that 
the prevalence of ME/CFS was much higher 
among members of families of people with the 
disease than in the general population. In 
genetically unrelated household contacts an 
intermediate level of prevalence was found, 
indicating a role for both genetic and 
environmental factors (Underhill and 
O'Gorman, 2006), while an increased 
propensity has been demonstrated among 
people with ME/CFS to a family history of 
endocrine or metabolic disorders, in 
comparison with normal controls (Torres-
Harding et al., 2004). The strong association 
with having a mother with ME/CFS, but lack of 
association with having a father with the 
condition, is consistent with ME/CFS being 
associated with disturbed mitochondrial 
function (Plioplys and Plioplys, 1995). 
Mitochondrial DNA is of course entirely of 
maternal origin. This finding is consistent with 
the demonstration by Myhill et al of a marked 
correlation between degree of incapacity in 
people with ME/CFS and mitochondrial 
dysfunction (Myhill et al., 2009). 
 
Early management is clearly a source of major 
problems for people with ME/CFS, and other 
research has demonstrated the extent of 
shortcomings in the primary care sector, which 
for most patients is where their initial contacts 
with the health care system take place. Raine 
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et al (2004) concluded, following group 
discussions with 46 English GPs, that they 
tended to  stereotype ME/CFS patients as 
being antisocial and in conflict with their 
doctors. This is consistent with a survey of 121 
Dutch GPs (Prins et al., 2000), which found 
that only half used the diagnosis CFS, mostly 
because of ignorance of the criteria. 68% of 
patients diagnosed themselves, and more than 
half of the GPs were relatively unsympathetic, 
had problems communicating with them and 
considered cooperation to be poor. Similarly, a 
survey of attitudes to and knowledge of 
ME/CFS of English GPs (Bowen et al., 2005) 
found that many lacked confidence in 
diagnosis (48%) or treatment (41%), though 
72% accepted ME/CFS as a recognisable 
clinical entity. 
 
It is clear that a good relationship with the GP 
from the outset of the illness is very important 
in achieving a good outcome and avoiding 
severe illness, but unhelpful attitudes and 
ignorance are still widespread in primary care. 
Levels of acceptance and knowledge of 
ME/CFS among doctors generally appear 
unsatisfactory (Ho-Yen and McNamara, 1991; 
Denz-Penhey and Murdoch, 1993; Steven et 
al., 2000). A recent survey of Irish GPs found 
that only 58% accepted ME/CFS as a genuine 
clinical entity (Fitzgibbon et al., 1997). 
Similarly, in a Brazilian survey less than one-
third of respondents mentioned ME/CFS as a 
possible diagnosis when presented with a 
ME/CFS case scenario (Nacul et al., 1998). A 
primary care based randomised controlled trial 
(Whitehead and Campion, 2002) produced an 
equivocal result because recruitment was 
poor, and drop out high, but the authors 
concluded that general practitioners cannot 
provide a coherent management programme, 
or indeed any effective treatment in primary 
care. The importance of appropriate 
management in the early stages of the illness 
was underlined by the Chief Medical Officer’s 
Working Group report, which stated: “Early 
recognition with an authoritative, positive 
diagnosis is key to improving outcomes” 
(CMO’s Working Group., 2002). Given that 
early management is clearly implicated in the 
subsequent development of severe disease, 
the finding of the Wichita survey that most 
cases of CFS in the population are 
unrecognised by the medical community is 
clearly important. The recognition rate in that 
study was only 16%, so clearly there is still a 
mountain to climb (Solomon and Reeves, 
2004). 
 
Previous research has demonstrated 
associations between various social factors 
and severe illness and poor prognosis. Social 
factors implicated include, for example, poor 
education and unemployment, while having a 
solicitous ‘significant other’ (Schmaling et al., 
2000) and being married (Hartz et al., 1999) 
have a protective effect. In adults, co morbidity 
can predispose to severe illness and poor 
prognosis (White et al., 2000). Our study has 
shown that personality is not a factor in the 
development of severe disease. While other 
studies have compared people with ME/CFS 
and normal controls (White and Schweitzer 
2000; Buckley et al., 1999; Rangel et al., 2000) 
or people with other illnesses (Van 
Houdenhove et al., 1995; Henderson and 
Tannock, 2004; Hickie et al., 1990; Pepper et 
al., 1993; Christodoulou et al., 1999; Wood 
and Wessely, 1999), or investigated 
determinants of disease duration, there do not 
appear to have been any previous studies 
comparing exposure to risk factors in mild and 
severe cases. It is, in any case, difficult to 
reach conclusions from these other studies 
because of the diversity of instruments used 
and traits investigated. A recent study (Le Bon 
et al., 2007) suggested that personality does 
not play a major role in CFS. This is consistent 
with our findings, which are also in line with 
those of the Dubbo study, in which persistence 
of post-infective CFS was largely related to the 
severity of the acute illness, rather than to 
demographic, psychological or microbiological 
factors. In particular, neuroticism was 
unrelated to the development of prolonged 
illness (Hickie et al., 2006). 
 
There is no consensus about the role of 
perfectionism in the development of ME/CFS 
from these studies. No differences in 
perfectionism between CFS subjects and 
controls were found in studies by Wood and 
Wessely (1999), Buckley et al (1999) and 
Blenkiron et al (1999). On the other hand, 
White and Schweitzer (2000) found higher 
levels on the Total Perfectionism score 
amongst the CFS group than among healthy 
controls. In a study of adolescents with CFS, 
conscientiousness was one of the personality 
features that were significantly more common 
(Rangel et al., 2000). Henderson & Tannock 
(Henderson and Tannock, 2004) found higher 
levels of Cluster C personality disorder (which 
includes perfectionism) in CFS and depressed 
patients than in healthy controls. 
 
The higher neuroticism scores in the mildly ill 
compared with the severely ill were not 
consistent with other studies which have found 
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neuroticism (in particular, depression) to be 
positively associated with ME/CFS (Buckley et 
al., 1999; Hickie et al., 1990; Pepper et al., 
1993; Blenkiron et al., 1999; Poulis,1999; 
Johnson et al., 1996).  Abbey et al (Abbey and 
Garfinkel, 1990) reports that high rates of 
symptoms of depression and of major 
depressive illness are among the most 
consistent findings in ME/CFS patients.  A 
review of studies published from 1982 to 1992 
(Manu et al., 1992) concluded that the majority 
of patients with CFS have a high prevalence of 
current major depression and abnormal 
personality traits. It is likely though that studies 
showing a positive association between 
ME/CFS and depression are reporting a 
consequence of the way in which ME/CFS 
patients are treated rather than an association 
with pre-morbid personality or pre-existing 
mental illness. 
 
The strength of this study was that it involved a 
large group of subjects manifesting a range of 
degrees of severity, and has demonstrated 
significant differences between mild and 
severe cases in exposure to a range of risk 
factors. The study sample was not selected to 
be representative of the ME/CFS population as 
a whole, but rather to manifest the range of 
severity found in the illness. There have few 
attempts in the past to quantify severity in 
reproducible ways, and most previous studies 
share a number of faults. Most are 
uncorroborated by other studies. Secondly, 
while they  may  have  speculated  about  
causation,  mostly  what  has  been  
demonstrated  are   associations. Definitions of 
severity have varied, and are often vague (Cox 
and Findley, 2000).  
 
Weaknesses of the study were that diagnoses 
could not be validated, were not independently 
verified, and were probably of variable quality. 
Consequently, the study population may have 
included people with unexplained chronic 
fatigue who did not have ME/CFS. Another 
problem derived from the necessarily arbitrary 
nature of the assignment of respondents to 
mild and severe categories, in an illness in 
which there appears to be a continuous 
spectrum of severity, in which symptomatology 
is multidimensional in nature, and in which the 
patient may manifest different levels of severity 
in respects of different clinical features, e.g. 
fatigue, physical disability, pain, or cognitive 
dysfunction. This was compounded by a lack 
of suitable validated instruments for measuring 
severity in this multidimensional context, 
existing instruments such as the Chalder 
Fatigue Scale (Chalder et al., 1993) and the 
Barthel Index (Mahoney and Barthel, 1965) 
being one-dimensional in nature. The low 
response rate may have introduced response 
bias, and, since this was a cross-sectional 
study, recollections may have been subject to 
recall bias. This could be overcome in future 
research by undertaking prospective cohort 
studies. 
 
The use of the Barthel Index caused some 
respondents serious misgivings. They 
explained that the way the questions were 
framed gave misleading information about 
their level of disability, portraying them as 
mildly ill when they should have been in the 
severe group. For example, on the 
questionnaire one respondent ticked ‘I can 
move completely independently’ but wrote in 
the margins, “I can move completely 
independently for a few metres but am 
basically too ill to use a standard wheelchair 
and am in bed 97% of the time.” Another 
respondent wrote, “The main problem is not so 
much with enacting something like feeding 
oneself, or climbing stairs. Problems arise with 
repetition and with delayed, post-exertional 
fatigue. The way you have laid out these 
questions cannot reflect 'how ill I am' and like 
the Benefits questionnaires which have 
caused many a ME sufferer to be denied 
benefit, they cannot elicit a true picture.”   
 
Another area of concern was with regard to 
personality testing. The instrument used, IPIP 
(Goldberg, 1999; Goldberg, 2001; IPIP, 2005), 
had not been validated for use by people with 
ME/CFS. The test was intended to reflect 
respondents’ pre-morbid personality but did 
not assess this directly. Questions were in the 
past tense and respondents were instructed to 
think back to how they were in the year before 
they first became ill with ME/CFS. Many 
respondents found this difficult, especially for 
those who had been ill for years and decades, 
who had been children when they first became 
ill or whose illness had a gradual, non-specific 
onset. “Having had ME for 6 years, it is 
sometimes difficult to remember what life was 
like as a "normal" person,” one respondent 
wrote. When viewed retrospectively, the 
responses are undoubtedly affected by recall 
bias. Even with the best of intentions, the 
personality scores reflected respondents’ 
current personality.  
 
Personality tests are designed for well people 
and are meant to be completed rapidly. 
Instructions to score 135 statements in 15 
minutes elicited useful feedback on the 
inappropriateness of these instructions for 
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people with ME/CFS. “Do you seriously expect 
brain fogged people to do the personality 
questions in 15 minutes or less, to cope with 
things like the double negatives involved and 
to remember accurately what they were like 
pre ME?” Multiple questions for each sub-
domain were included for greater accuracy, 
but the cognitive dysfunction associated with 
ME/CFS, together with fatigue, may have 
contributed to inaccuracy.  
 
The existence of a personality test in the 
questionnaire angered some people and may 
have contributed to the low response rate. 
Some of the comments made by respondents 
illustrate the strength of feeling about the role 
of personality in ME/CFS, e.g.: “I hope no one 
answers this totally biased questionnaire. I 
have a physical illness!!!” and “I had hoped this 
old chestnut had been buried long since about 
perfectionist personality being a factor in 
severe ME. If any substance to it, then there 
would be a veritable epidemic of ME among 
chief executives and the driven personalities of 
the city.” This was no great surprise. There is 
widespread and deep-seated sensitivity 
among people with ME/CFS regarding 
suggestions that ME/CFS is primarily 
psychological in nature, to the extent that even 
to ask questions of this nature elicits antipathy, 
even though it is necessary to undertake 
research in this area if the hypotheses 
considered objectionable by people with 
ME/CFS are to be rejected.  
 
Conclusion 
Family history was a risk factor for severe 
ME/CFS. The strong association with having a 
mother with ME/CFS, but lack of association 
with having a father with the condition, is 
consistent with ME/CFS being associated with 
disturbed mitochondrial function. Being female 
was also a risk factor for severe disease. Early 
management of ME/CFS appeared also to be 
a major determinant of severity, with all but 
one of the variables in the final logistic 
regression model pertaining to the 
management of the condition in its early 
stages.  
 
Personality type did not appear to constitute a 
risk factor for severe disease. There was an 
inverse association between neuroticism and 
severity, but none overall between 
conscientiousness and severity. Mean scores 
for neuroticism were consistently higher 
among mildly ill subjects than among the 
severely ill, which may indicate either that 
severely ill people may develop a degree of 
stoicism that affects their responses to 
personality questionnaires, or that the mild 
category included some people whose 
illnesses were not ME/CFS at all, but other 
fatiguing conditions which may have been 
related to personality. There was no 
association overall of conscientiousness with 
severity, but, among the sub-domains of 
conscientiousness, self-efficacy and self-
discipline were more marked among the 
severe cases, which may indicate that only the 
most motivated of severely ill people 
persevered to the end of the questionnaire.  
 
The examination of possible associations with 
other pre-illness exposures and with 
biomedical factors was inconclusive, and more 
research is clearly needed in this area.  
 
 
Acknowledgements 
Thanks are due to the ME Association, for 
funding the research, and for distributing the 
questionnaire to members of the ME 
Association, and to the other organisations 
that participated. These are the 25% Group 
and CHROME, which distributed 
questionnaires to their members, and the 
National ME Centre (Professor Leslie Findley) 
and the Wiltshire ME Service (Dr. Martin Lee), 
both of which distributed questionnaires to 
their patients. Finally, we are very grateful to 
all those participants who completed and 
returned questionnaires, for contributing their 
data and supporting the project. 
 
 
References 
 
Abbey SE, Garfinkel PE, 1990. Chronic Fatigue 
Syndrome and the Psychiatrist. Canadian Journal of 
Psychiatry, 35(7): 625-633. 
Action for ME, 2001. Severely Neglected. London. 
Bass C, 2001. Does Myalgic Encephalomyelitis 
exist? The Lancet, 357: 1889. 
Bell KM, Cookfair D, Bell DS, Reese P, Cooper L, 
1991. Risk factors associated with chronic fatigue 
syndrome in a cluster of pediatric cases. Reviews of 
Infectious Diseases, 13 Suppl 1: S32-8. 
Blenkiron P, Edwards R, Lynch S, 1999.  
Associations between perfectionism, mood, and 
fatigue in Chronic Fatigue Syndrome: a pilot study. 
The Journal of Nervous and Mental Disease, 
187(9): 566-570. 
Bowen J, Pheby D, Charlett A, McNulty C, 2005. 
Chronic Fatigue Syndrome: a survey of GPs’ 
attitudes and knowledge. Family Practice, 22(4): 
389-393. 
Research Article      Biology and Medicine, Vol 1 (4): 50-74, 2009 
72 
 
Buckley L, MacHale SM, Cavanagh JT, Sharpe M, 
Dearie M, Lawrie SM, 1999. Personality dimensions 
in CFS and depression, Journal of Psychosomatic 
Research, 46(4): 395-400. 
Christodoulou C, Deluca J,  Johnson SK, Lange G, 
Gaudino EA, Natelson S, 1999. Examination of 
Cloninger's basic dimensions of personality in 
fatiguing illness, chronic fatigue syndrome and 
multiple sclerosis. Journal of Psychosomatic 
Research, 47(6): 597-607. 
Chalder T, Berelowitz G, Pawlikowska T, Watts L, 
Wessely S, Wallace EP, 1993. Development of a 
fatigue scale. Journal of Psychosomatic Research, 
37: 147-53. 
Chubb HL, Jones I, Hillier J, Moyle C, Sadler S, 
Cole T, Redman K, Farmer A, 1999. Chronic 
Fatigue Syndrome - Personality and Attributional 
Style of Patients in Comparison to Healthy Controls 
and Depressed Individuals. Journal of Mental 
Health, 8(4): 351-359. 
Clark MR, Katon W, Russo J, Kith P, Sintay M, 
Buchwald D, 1995 Chronic fatigue: risk factors for 
symptom persistence in a 2 1/2-year follow-up 
study. American Journal of Medicine, 98(2): 187-95. 
ME/CFS Working Group. Report to the Chief 
Medical Officer of an Independent Working Group, 
2002. London: Department of Health. Ch4, p31. 
Cox, DL, Findley, LJ, 2000. Severe and very severe 
patients with chronic fatigue syndrome perceived 
outcome following an inpatient programme. Journal 
of Chronic Fatigue Syndrome, 7(3): 33-47. 
Denz-Penhey H, Murdoch JC, 1993. General 
practitioners acceptance of the validity of chronic 
fatigue syndrome as a diagnosis. New Zealand 
Medical Journal,106(953): 122-124. 
Farmer A, Scourfield J, Martin N, Cardno A, 
McGuffin P,  1999. Is disabling fatigue in childhood 
influenced by genes? Psychological Medicine, 
29(2): 279-82. 
Fitzgibbon EJ, Murphy D, O'Shea K, Kelleher C, 
1997. Chronic debilitating fatigue in Irish general 
practice: a survey of general practitioners' 
experience. British Journal of General Practice, 
47(423): 618-622. 
Goldberg LR, 1999. A broad-bandwidth, public 
domain, personality inventory measuring the lower-
level facets of several five-factor models. In 
Personality Psychology In Europe, Eds., Mervielde 
I,  Deary I, De Fruyt F, Ostendorf F, Tilburg, 
Netherlands: Tilburg University Press, pp 7-28.  
Goldberg LR, 2001. The comparative validity of 
adult personality inventories: applications of a 
consumer-testing framework. In Handbook of Adult 
Personality Inventories, Eds., Briggs SR, Cheek JM,  
Donahue EM, New York: Plenum; pp 165-178. 
Hamacheck DE, 1978. Psychodynamics of normal 
and neurotic perfectionism. Psychology, 15: 27 – 
33. 
Hartz AJ. Kuhn EM. Bentler SE, Levine PH, London 
R, 1999. Prognostic factors for persons with 
idiopathic chronic fatigue. Archives of Family 
Medicine, 8(6): 495-501. 
Henderson M, Tannock C, 2004. Objective 
assessment of personality disorder in Chronic 
Fatigue Syndrome, Journal of Psychosomatic 
Research, 56: 251-254. 
Hickie I, Lloyd A, Wakefield D, Parker G, 1990. The 
psychiatric status of patients with the Chronic 
Fatigue Syndrome. British Journal of Psychiatry, 
156: 534-540. 
Hickie I, Davenport T, Wakefield D, Vollmer-Conna 
U, Cameron B, Vernon SD, Reeves WC, Lloyd A  
(for the Dubbo Infection Outcomes Study Group), 
2006. Post-infective and chronic fatigue syndromes 
precipitated by viral and non-viral pathogens: 
prospective cohort study. British Medical Journal, 
333: 575. 
Johnson SK, Deluca J, Natelson BH, 1996. 
Personality Dimensions in the Chronic Fatigue 
Syndrome: A Comparison with Multiple Sclerosis 
and Depression. Journal of Psychiatric Research, 
30: 9-20. 
Hill NF, Tiersky LA, Scavalla VR, Lavietes M, 
Natelson BH, 1999. Natural history of severe 
chronic fatigue syndrome. Archives of Physical 
Medicine and Rehabilitation, 80(9): 1090-4. 
Ho-Yen DO, McNamara I, 1991. General 
practitioners’ experience of chronic fatigue 
syndrome. British Journal of General Practice, 
41(349): 342-346. 
International Personality Item Pool, 2001. A 
Scientific Collaboratory for the Development of 
Advanced Measures of Personality Traits and Other 
Individual Differences. Available at: 
http://ipip.ori.org. Accessed February 26, 2005.  
Joyce J, Hotopf M, Wessely S, 1997. The prognosis 
of chronic fatigue and chronic fatigue syndrome: a 
systematic review. Quarterly Journal of Medicine, 
90(3): 223-33. 
Le Bon O, Cappeliez B, Neu D, Stulens L, 
Hoffmann G, Hansenne M, Lambrecht L, Ansseau 
M, Linkowski P, 2007. Personality profile of patients 
with chronic fatigue syndrome. Journal of Chronic 
Fatigue Syndrome, 14(1): 55-68. 
Research Article      Biology and Medicine, Vol 1 (4): 50-74, 2009 
73 
 
Levine PH, 1997. Epidemiologic advances in 
chronic fatigue syndrome. Journal of Psychiatric 
Research, 31: 7-18. 
MacDonald KL, Osterholm MT, LeDell KH, White 
KE, Schenck CH, Chao CC, Persing DH, Johnson 
RC, Barker JM, Peterson PK, 1996. A case-control 
study to assess possible triggers and cofactors in 
chronic fatigue syndrome. American Journal of 
Medicine, 100: 548-54. 
Mahoney FI, Barthel D, 1965. Functional 
Evaluation: The Barthel Index. Maryland State 
Medical Journal, 14 56-61. (Used With Permission). 
Manu P, Lane TJ, Matthews DA, 1992. The 
Pathophysiology of Chronic Fatigue Syndrome: 
Confirmations, Contradictions, and Conjectures. 
International Journal of Psychiatry in Medicine, 
22(4): 397-408. 
Myhill S, Booth NE, McLaren-Howard J, 2009. 
Chronic fatigue syndrome and mitochondrial 
dysfunction. International Journal of Clinical and 
Experimental Medicine, 2: 1-16. 
Nacul, LC, Pereira, FLR, Jaques, GA, Ramos, AG, 
Rodrigues, CJA, Oliva, IB, Gonçalves, NR, Almeida, 
RC, 1998. What do doctors and health workers of 
North-East Brazil know and so about chronic fatigue 
syndrome? American Conference of Chronic 
Fatigue Syndrome, Cambridge-MA, USA. 
Peakman M, Deale A, Field R, Mahalingam M, 
Wessely S, 1997. Clinical improvement in chronic 
fatigue syndrome is not associated with lymphocyte 
subsets of function or activation. Clinical 
Immunology and Immunopathology, 82: 83-91. 
Pepper CM, Krupp LB, Friedberg F, 1993. A 
Comparison of neuropsychiatric characteristics in 
chronic fatigue syndrome, multiple sclerosis and 
major depression. Journal of Neuropsychiatry and 
Clinical Neurosciences, 5: 200-205. 
Pheley AM. Melby D. Schenck C, Mandel J, 
Peterson PK,1999. Can we predict recovery in 
chronic fatigue syndrome?.Minnesota Medicine, 
82(11): 52-6. 
Plioplys AV, Plioplys S, 1995. Serum levels of 
carnitine in chronic fatigue syndrome: clinical 
correlates. Neuropsychobiology, 32(3): 132-8. 
Poulis U, 1999. Alexithymia and Chronic Fatigue 
Syndrome: A Correlational Self-Report Study. 
Dissertation Abstracts International Section B - The 
Sciences and Engineering, 60(6-B): 2957. 
Prins JB, Bleijenberg G, Rouweler EK, van Weel C, 
van der Meer JWM, 2000. Doctor-patient 
relationship in primary care of chronic fatigue 
syndrome: perspectives of the doctor and the 
patient. JCFS, 7(4): 3-15. 
Raine R, Carter S, Sensky T, Black N, 2004. 
General practitioners' perceptions of chronic fatigue 
syndrome and beliefs about its management, 
compared with irritable bowel syndrome: qualitative 
study. British Medical Journal, 328: 1354-1357. 
Rangel L, Garralda ME, Levin M, Roberts H, 2000. 
The course of severe chronic fatigue syndrome in 
childhood. Journal of Royal Society of Medicine, 
93:129-34. 
Rangel L, Garralda E, Levin M, Roberts H, 2000. 
Personality in adolescents with Chronic Fatigue 
Syndrome, European Child and Adolescent 
Psychiatry, 9(1): 39-45. 
Ray C, Weir WR, Cullen S, Phillips S, 1992. Illness 
perception and symptom components in chronic 
fatigue syndrome. Journal of Psychosomatic 
Research, 36(3): 243-56. 
Schmaling KB, Smith WR, Buchwald DS, 2000. 
Significant other responses are associated with 
fatigue and functional status among patients with 
chronic fatigue syndrome. Psychosomatic Medicine, 
62(3): 444-50. 
Solomon L, Reeves WC, 2004.  Factors influencing 
the diagnosis of chronic fatigue syndrome. Archives 
of Internal Medicine, 164: 2241-2245. 
Steven ID, McGrath B, Quereshi F, Wong C, Chern 
I, Pearn-Rowe B, 2000. General practitioners’ 
beliefs, attitudes and reported actions towards 
chronic fatigue syndrome. Australian Family 
Physician, 29(1): 80-85. 
Taylor RR, Jason LA, Curie CJ, 2002. Prognosis of 
chronic fatigue in a community-based sample. 
Psychosomatic Medicine, 64(2): 319-327.  
Torres-Harding SR, Jason LA, Dicle Turkoglu O, 
2004. Family Medical History of Persons with 
Chronic Fatigue Syndrome . Journal of Chronic 
Fatigue Syndrome, 12(4): 25 – 35.  
Underhill R, O'Gorman RL, 2006. Prevalence of 
Chronic Fatigue Syndrome and Chronic Fatigue 
Within Families of CFS Patients. Journal of Chronic 
Fatigue Syndrome, 13(1): 3 – 13. 
Van Hoof E, De Meirleir K, 2007.The Influence of 
Chronic Fatigue Syndrome on the Personality 
Profile: A Case Report. Journal of Chronic Fatigue 
Syndrome , 12(3): 63 – 71. 
Van Houdenhove B, Onghena P, Neerinckx E, 
Hellin J, 1995. Does high 'action-proneness' make 
people more vulnerable to chronic fatigue 
syndrome? A controlled psychometric study. 
Journal of Psychosomatic Research, 39(5): 633-40. 
Wernham W, Pheby D, Saffron L, 2005. Risk 
Factors for the Development of Severe ME/CFS – A 
Research Article      Biology and Medicine, Vol 1 (4): 50-74, 2009 
74 
 
Pilot Study. Journal of Chronic Fatigue Syndrome, 
12(2): 47-50. 
White C, Schweitzer R, 2000. The role of 
personality in the development and perpetuation of 
Chronic Fatigue Syndrome. Journal of 
Psychosomatic Research, 48: 515 – 524. 
White KP, Speechley M, Harth M, Ostbye T, 2000. 
Co-existence of chronic fatigue syndrome with 
fibromyalgia syndrome in the general population: a 
controlled study. Scandinavian Journal of 
Rheumatology, 29: 44-51. 
Whitehead L, Campion P, 2002. Can General 
Practitioners Manage Chronic Fatigue Syndrome? 
A Controlled Trial. Journal of Chronic Fatigue 
Syndrome, 10(1): 55 – 64. 
Wilson A, Hickie I, Lloyd A, Hadzi-Pavlocic D, 
Wakefield D, 1995. Cell-mediated immune function 
and the outcome of chronic fatigue syndrome. 
International Journal of Immunopharmacology, 17: 
691-94. 
Wood B, Wessely, S, 1999. Personality and social 
attitudes in Chronic Fatigue Syndrome, Journal of 
Psychosomatic Research, 47(4): 385-397. 
